ArticleBMC health services research2026
The Turkish version of the self-management efficacy questionnaire for patients with psoriasis: cross-cultural adaptation and psychometric evaluation.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPsoriasis is a chronic condition requiring sustained outpatient follow-up, patient education, and coordinated nursing care. Effective self-management is essential for supporting individualized patient education, guiding nursing care planning, and evaluating outpatient service outcomes; however, disease-specific tools to assess self-management efficacy are limited in Türkiye.
methodsThis methodological study aimed to conduct the Turkish cross-cultural adaptation and psychometric evaluation of the Self-Management Efficacy Questionnaire for Patients with Psoriasis (SMEQ-PSO), originally developed by Sun et al. The study included 147 patients with psoriasis vulgaris attending a dermatology outpatient clinic. Content validity was assessed using expert evaluation, while construct validity was examined through exploratory and confirmatory factor analyses. Reliability was evaluated using Cronbach’s alpha, McDonald’s omega, and split-half methods.
resultsAmong 147 participants, 55.1% were male, with an average age of 45.16 (± 14.83) years. S-CVI/Ave was 0.97. EFA revealed a five-factor structure explaining 70.5% of the variance (KMO = 0.92). CFA showed acceptable model fit (χ²/df = 1.61, RMSEA = 0.07, CFI = 0.92). Cronbach’s α and McDonald’s Omega were both 0.95.
conclusionsThe Turkish SMEQ-PSO is a valid and reliable instrument for assessing self-management efficacy among patients with psoriasis. Beyond individual assessment, the scale may support nursing-led care planning, targeted patient education, and evaluation of outpatient service delivery in chronic dermatological care settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.